Skip to content
FIND A HEALTH VALLEY ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

Latest BioAlps news
Deloitte - BioAlps - Report

Unlocking the New Window for Digital Health in the Swiss Health Valley

BioAlps – Swiss Health Valley and Deloitte Switzerland have joined forces to publish a new report, Unlocking the new window…

Edwards Lifesciences receives the BioAlps – Swiss Health Valley Industry Award at the BioAlps Networking Day 2026

BioAlps – Swiss Health Valley presented its Industry Award to Edwards Lifesciences, the leading global structural heart innovation company, today…

Prix BioAlps - Centre de Vaccinologie HUG

The HUG Vaccinology Centre receives the BioAlps – Swiss Health Valley Academia Award

The Vaccinology Centre of the Geneva University Hospitals (HUG) and the University of Geneva (UNIGE) is the 2026 winner of…

Datarium at BND

Datarium at BioAlps Networking Day

Exploring the data of life during the BioAlps Networking Day with the Datarium exhibition created by the Swiss Institute of…

Neurosterix

Neurosterix Announces $105 Million Series B Financing 

Neurosterix, a Geneva-based clinical-stage biotechnology company developing novel, selective allosteric modulators for neuropsychiatric disorders, announced the closing of a $105…

Bewe Lab Team 2026

Bewe Lab Gets Support from Lichtsteiner Foundation

Changing eating and drinking habits doesn’t have to start with restriction. Bewe Lab, a spinoff of the University of Fribourg…

SBA - Nomination - V2

Swiss Biotech Association appoints Nicolas Durand as CEO and Odile Rundquist as Chief Strategy & Growth Officer

The Swiss Biotech Association has appointed Nicolas Durand as CEO, effective 1 January 2027, and Odile Rundquist as Chief Strategy & Growth Officer, as…

ExcellGene 25 years

ExcellGene celebrates 25 years of biotechnology innovation

Based in Monthey (VS) since 2003, ExcellGene last week celebrated 25 years of biotechnology innovation also marking the leadership transition…

HUG - Dr Juan F. Iglesias

HUG to Lead a Major Trial Testing Cell Therapy for Advanced Heart Failure

Geneva University Hospitals (HUG) has received over CHF 1 million from the Swiss National Science Foundation to take part in…

CSS Study - IA Health

Twice as many Swiss now ask AI about their symptoms

The 2026 CSS Health Study shows chatbots are fast becoming part of how people in Switzerland manage their health, from…

Ibex Therapeutics

Ibex Therapeutics Secures CHF 640,000 in Grant Funding from Innosuisse

The Valais-based start-up is accelerating the development of its lead candidate in partnership with the Geneva University Hospitals (HUG) and…

Apolarion

Apolarion receives CHF 150,000 from Venture Kick

The EPFL spin-off Apolarion has obtained CHF 150,000 from Venture Kick to advance a chemical-free seed treatment technology powered by…